Email Alert | RSS

Journal of Peking University(Health Sciences) ›› 2019, Vol. 51 ›› Issue (6): 1036-1041. doi: 10.19723/j.issn.1671-167X.2019.06.010

Previous Articles     Next Articles

Effect of methyl eugenol on nasal mucosal aquaporin 5 in rats with allergic rhinitis

Nan WU1,Xiu-li ZHANG1,Yun HOU2,Li-xing LIN3,△(),Xiao-bing ZHANG2,△()   

  1. 1. The First Clinical Medical College of Lanzhou University, Lanzhou 730000, China
    2. Department of Otolaryngology, The First Affiliated of Lanzhou University, Lanzhou 730000, China
    3. Pediatrics, The First Affiliated of Lanzhou University, Lanzhou 730000, China
  • Received:2017-12-14 Online:2019-12-18 Published:2019-12-19
  • Contact: Li-xing LIN,Xiao-bing ZHANG E-mail:lxlin.lzu@163.com;790736924@qq.com
  • Supported by:
    Supported by the National Natural Science Foundation of China(81450052)

RICH HTML

 12   

PDF (PC)

253

Abstract:

Objective: To observe the effect of methyl eugenol on the expression of aquaporin (AQP) 5 in nasal mucosa of rats with allergic rhinitis and to explore its significance.Methods: In the study, 128 Wistar rats were randomly divided into normal control group, AR model control group, budesonide positive control group, 80 mg/kg group, 40 mg/kg group, 20 mg/kg group and 10 mg/kg group, and ovalbumin (OVA) was used to establish the model of allergic rhinitis. After successful modeling, castor oil, budesonide and corresponding doses of methyl eugenol were given respectively. After 1, 2 and 4 weeks of administration, the distribution of AQP5 in nasal mucosa was observed by immunohistochemistry. The expression of AQP5 in nasal mucosa of each group was compared by Western blotting. The expression of AQP5 mRNA was compared with real-time PCR.Results: AQP5 was mainly located in the glandular epithelium and ductal epithelial cell membrane and cytoplasm. The expression of AQP5 and AQP5 mRNA in nasal mucosa of the rats in the model control group was lower than that in the normal control group (P<0.05). AQP5 and AQP5 mRNA in nasal mucosa of the rats in each treatment group were higher than those in the model control group in varying degrees. The expression of AQP5 in the budesonide group was not significantly different from that in the normal control group 1, 2 and 4 weeks after drug intervention(P>0.05), but there was significant difference between the budesonide group and the model control group (P<0.05). The expression of AQP5 mRNA in the budesonide group was significantly different from that in the normal control group and the model control group (P<0.05).After 2 weeks of intervention, the expression of AQP5 in each dose group of methyleugenol was not significantly different from that in the budesonide group (P>0.05). After 1 week of intervention, there was no significant difference in AQP5 mRNA between the 20 mg/kg group and the normal control group (P>0.05), but there was significant difference between the 20 mg/kg group and the model control group (P<0.05).Conclusion: Methyl eugenol may increase the degree of edema of the nasal mucosa by reducing the expression of AQP5 and reduce the secretion of glands, thus alleviating the symptoms of allergic rhinitis, sneezing and runny nose.

Key words: Methyl eugenol, Aquaporin 5, Allergic rhinitis

CLC Number: 

  • R765.21

Figure 1

The distribution of AQP5 in the nasal mucosa of rats (SP ×400) A and B, Expression of AQP5 in normal control group of rat nasal mucosa; C and D, expression of AQP5 in nasal mucosa of rats in AR model control group."

Figure 2

The expression of AQP5 in the nasal mucosa of rats C, control group; A, AR model control group; B, budesonide positive control group; 80, 80 mg/kg group; 40, 40 mg/kg group; 20, 20 mg/kg group; 10, 10 mg/kg group; W, week(s). *P<0.05, comparison with normal control group; ▲ P<0.05, comparison with AR model control group; ◆ P<0.05, comparison with budesonide positive control group."

Figure 3

The expression of AQP5 mRNA in the nasal mucosa of rats C, control group; A, AR model control group; B, budesonide positive control group; 80, 80 mg/kg group; 40, 40 mg/kg group; 20, 20 mg/kg group; 10, 10 mg/kg group; W, week(s). *P<0.05, comparison with normal control group; ▲ P<0.05, comparison with AR model control group; ◆ P<0.05, comparison with budesonide positive control group."

[1] 孟楠楠, 候赟, 桂岩 , 等. 甲基丁香酚对变应性鼻炎大鼠鼻黏膜组织中黏蛋白5AC的影响[J]. 浙江大学学报(医学版), 2016,45(5):476-484.
[2] Shin BK, Lee EH, Kim HM . Suppression of L-histidine decar-boxylase mRNA expression by methyleugenol[J]. Biochem Biophys Res Commun, 1997,232(1):188-191.
[3] 赵秀杰, 董震, 杨占泉 , 等. 鼻超敏反应实验模型的建立[J]. 中华耳鼻咽喉科杂志, 1993,28(1):17-18.
[4] 彭瑶, 连增林, 张晓阳 , 等. 祛风胜湿方对变应性鼻炎小鼠免疫球蛋白E及水通道蛋白5的影响[J]. 医学研究杂志, 2015,44(6):39-41.
[5] 周斌, 吕世静, 陈向阳 , 等. 变应性鼻炎红细胞和淋巴细胞免疫黏附功能和两种细胞因子的检测[J]. 中华耳鼻咽喉科杂志, 2000,35(6):50-52.
[6] 洪苏玲, 黄江菊, 杨玉成 . 变应性鼻炎患者血清中四种细胞因子的检测[J]. 中华耳鼻咽喉科杂志, 2002,37(4):76-77.
[7] 薛金梅, 赵海亮, 安云芳 , 等. 大鼠变应性鼻炎模型鼻黏膜P物质受体mRNA的表达[J]. 中华耳鼻咽喉科杂志, 2004,10(4):19-23.
[8] 张旭, 袁金凤, 刘重光 . 变应性鼻炎大鼠鼻黏膜Ca~(2+)-ATP酶的表达[J]. 辽宁医学杂志, 2003,17(1):12-14.
[9] Barnes PJ . Molecular mechanisms of corticosteroids in allergic diseases[J]. Allergy, 2001,56(10):928-936.
[10] 国家药典委员会. 中国药典[M]. 北京: 中国医药科技出版社, 2010: 159.
[11] Wang BB, Qi W, WANG LL , et al. Comparative study of chemical composition, antinociceptive effect and acute toxcity of the essential oils of three asarum drugs[J]. Chin Pharm J, 2014,23(7):480-489.
[12] 谢伟, 陆满文 . 毛细辛挥发油的中枢抑制、解热镇痛和抗炎作用[J]. 中国药理学通报, 1993,9(5):389.
[13] 王玉生 . 中药药理与应用[M]. 北京: 人民卫生出版社, 1983: 46-48.
[14] 周荣汉 . 中药资源学[M]. 北京: 中国医药科技出版社, 1993: 202.
[15] Li C, Xu F, Xie DM , et al. Identification of absorbed constituents in the rabbit plasma and cerebrospinal fluid after intranasal administration of Asari Radix et Rhizoma by HS-SPME-GC-MS and HPLC-APCI-IT-TOF-MSn[J]. Molecules, 2014,19(4):4857-4879.
[16] 杨华, 徐风, 万丹 , 等. 甲基丁香酚镇痛抗炎作用及机制研究[J]. 中药新药与临床药理, 2017,28(3):292-297.
[17] Yasui M, Serlachius E, Lofgren M , et al. Perinatal changes in expression of aquaporin-4 and other water and ion transporters in rat lung[J]. J Physiol, 1997,505(1):3-11.
[18] Shen Y, Wang Y, Chen Z , et al. Role of aquaporin 5 in antigen-induced airway inflammation and mucous hyperproduction in mice[J]. J Cell Mol Med, 2011,15(6):1355-1363.
[19] Nejsum LN, Kwon TH, Jensen UB , et al. Functional requirement of aquaporin-5 in plasma membranes of sweat glands[J]. Proc Natl Acad Sci USA, 2002,99(1):511-516.
[20] Song Y, Verknum AS . Aquauaporin-5 dependent fluid secretion in airway submucosal glands[J]. J Biol Chem, 2001,276(44):41288-41292.
[21] Montminy MR, Sevarino KA, Wagner JA , et al. Identification of cyclic-AMP-responsive elementwithin the rat somatostatain gene[J]. Proc Natl Acad Sci USA, 1986,83(18):6682-6686.
[22] Mobasheri A, Airley R, Hewitt SM . Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays[J]. Int J Oncol, 2005,26(5):1149-1158.
[23] Wang W, Zheng M . Nuclear factor kappa B pathway down-regulates aquaporin 5 in the nasal mucosa of rats with allergic rhinitis[J]. Eur Arch Otorhinolaryngol, 2011,268(1):73-81.
[24] Moine P, McIntyre R, Schwartz MD, et al. NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome[J]. Shock (Augusta, Ga), 2000,13(2):85-91.
[25] Towne JE, Krane CM, Bachurski CJ , et al. Tumor necrosis factor-alpha inhibits aquaporin 5 expression in mouse lung epithelial cells[J]. J Bio Chem, 2001,276(22):18657-18664.
[26] Ginsberg HS, Moldawer LL, Sehgal PB , et al. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia[J]. Proc Natl Acad Sci USA, 1991,88(5):1651-1655.
[27] Towne JE, Harrod KS, Krane CM , et al. Decreased expression of aquaporin (AQP)1 and AQP5 in mouse lung after acute viral infection[J]. Am J Respir Cell Mol Biol, 2000,22(1):34-44.
No related articles found!
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2010, 42(1): 82 -84 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 351 -354 .
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd